These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36889201)

  • 1. Wang resin catalysed sonochemical synthesis of pyrazolo[4,3-d]pyrimidinones and 2,3-dihydroquinazolin-4(1H)-ones: Identification of chorismate mutase inhibitors having effects on Mycobacterium tuberculosis cell viability.
    Shukla S; Nishanth Rao R; Bhuktar H; Edwin RK; Jamma T; Medishetti R; Banerjee S; Giliyaru VB; Shenoy GG; Oruganti S; Misra P; Pal M
    Bioorg Chem; 2023 May; 134():106452. PubMed ID: 36889201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium tuberculosis chorismate mutase: A potential target for TB.
    Khanapur M; Alvala M; Prabhakar M; Shiva Kumar K; Edwin RK; Sri Saranya PS; Patel RK; Bulusu G; Misra P; Pal M
    Bioorg Med Chem; 2017 Mar; 25(6):1725-1736. PubMed ID: 28202315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pd/Cu-catalyzed access to novel 3-(benzofuran-2-ylmethyl) substituted (pyrazolo/benzo)triazinone derivatives: their
    Reddy GS; Shukla S; Bhuktar H; Hossain KA; Edwin RK; Giliyaru VB; Misra P; Pal M
    RSC Adv; 2022 Sep; 12(41):26686-26695. PubMed ID: 36275143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel alkynyl substituted 3,4-dihydropyrimidin-2(1H)-one derivatives as potential inhibitors of chorismate mutase.
    Mallikarjuna Rao V; Mahesh Kumar P; Rambabu D; Kapavarapu R; Shobha Rani S; Misra P; Pal M
    Bioorg Chem; 2013 Dec; 51():48-53. PubMed ID: 24012092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and structure optimization of a series of isatin derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors.
    Jeankumar VU; Alokam R; Sridevi JP; Suryadevara P; Matikonda SS; Peddi S; Sahithi S; Alvala M; Yogeeswari P; Sriram D
    Chem Biol Drug Des; 2014 Apr; 83(4):498-506. PubMed ID: 24636345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and structure-activity relationship study of carvacrol derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors.
    Alokam R; Jeankumar VU; Sridevi JP; Matikonda SS; Peddi S; Alvala M; Yogeeswari P; Sriram D
    J Enzyme Inhib Med Chem; 2014 Aug; 29(4):547-54. PubMed ID: 24090423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 3-indolylmethyl substituted (pyrazolo/benzo)triazinone derivatives under Pd/Cu-catalysis: Identification of potent inhibitors of chorismate mutase (CM).
    Reddy GS; Snehalatha AV; Edwin RK; Hossain KA; Giliyaru VB; Hariharapura RC; Gautham Shenoy G; Misra P; Pal M
    Bioorg Chem; 2019 Oct; 91():103155. PubMed ID: 31400552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-N bond formation under Cu-catalysis: synthesis and in vitro evaluation of N-aryl substituted thieno[2,3-d]pyrimidin-4(3H)-ones against chorismate mutase.
    Adepu R; Shiva Kumar K; Sandra S; Rambabu D; Rama Krishna G; Malla Reddy C; Kandale A; Misra P; Pal M
    Bioorg Med Chem; 2012 Sep; 20(17):5127-38. PubMed ID: 22863527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand based virtual screening and biological evaluation of inhibitors of chorismate mutase (Rv1885c) from Mycobacterium tuberculosis H37Rv.
    Agrawal H; Kumar A; Bal NC; Siddiqi MI; Arora A
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3053-8. PubMed ID: 17418569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
    Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
    Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against
    Venugopala KN; Tratrat C; Pillay M; Chandrashekharappa S; Al-Attraqchi OHA; Aldhubiab BE; Attimarad M; Alwassil OI; Nair AB; Sreeharsha N; Venugopala R; Morsy MA; Haroun M; Kumalo HM; Odhav B; Mlisana K
    Drug Des Devel Ther; 2020; 14():1027-1039. PubMed ID: 32214795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains.
    da Silva Araújo A; Moraes AM; Lourenço MCS; Pessoa CO; da Silva ET; de Souza MVN
    Curr Top Med Chem; 2019; 19(9):683-689. PubMed ID: 30836914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purified recombinant hypothetical protein coded by open reading frame Rv1885c of Mycobacterium tuberculosis exhibits a monofunctional AroQ class of periplasmic chorismate mutase activity.
    Prakash P; Aruna B; Sardesai AA; Hasnain SE
    J Biol Chem; 2005 May; 280(20):19641-8. PubMed ID: 15737998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1H-Benzo[d]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity.
    Macchi FS; Pissinate K; Villela AD; Abbadi BL; Rodrigues-Junior V; Nabinger DD; Altenhofen S; Sperotto N; da Silva Dadda A; Subtil FT; de Freitas TF; Erhart Rauber AP; Borsoi AF; Bonan CD; Bizarro CV; Basso LA; Santos DS; Machado P
    Eur J Med Chem; 2018 Jul; 155():153-164. PubMed ID: 29885576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis.
    Nandikolla A; Srinivasarao S; Khetmalis YM; Kumar BK; Murugesan S; Shetye G; Ma R; Franzblau SG; Sekhar KVGC
    Toxicol In Vitro; 2021 Aug; 74():105137. PubMed ID: 33684466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 2.15 A crystal structure of Mycobacterium tuberculosis chorismate mutase reveals an unexpected gene duplication and suggests a role in host-pathogen interactions.
    Qamra R; Prakash P; Aruna B; Hasnain SE; Mande SC
    Biochemistry; 2006 Jun; 45(23):6997-7005. PubMed ID: 16752890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Devi PB; Nallangi R; Yogeeswari P; Sriram D
    Eur J Med Chem; 2013 Nov; 69():356-64. PubMed ID: 24077526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When inhibitors do not inhibit: critical evaluation of rational drug design targeting chorismate mutase from Mycobacterium tuberculosis.
    Munack S; Leroux V; Roderer K; Ökvist M; van Eerde A; Gundersen LL; Krengel U; Kast P
    Chem Biodivers; 2012 Nov; 9(11):2507-27. PubMed ID: 23161632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives.
    Venugopala KN; Al-Shar'i NA; Dahabiyeh LA; Hourani W; Deb PK; Pillay M; Abu-Irmaileh B; Bustanji Y; Chandrashekharappa S; Tratrat C; Attimarad M; Nair AB; Sreeharsha N; Shinu P; Haroun M; Kandeel M; Balgoname AA; Venugopala R; Morsy MA
    Antibiotics (Basel); 2022 Jun; 11(7):. PubMed ID: 35884084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
    Bakr RB; Mehany ABM; Abdellatif KRA
    Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.